Exhibit 16.1


December 5, 2019


Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549


Ladies and Gentlemen:


We have read Item 4.01 of Form 8-K dated December 5, 2019 of Boston Therapeutics, Inc. (the “Company”) and agree with the statements relating only to Liggett & Webb, P.A. contained therein. We have no basis to agree or disagree with other statements of the Company contained therein.


/s/ Liggett & Webb, P.A.